Maxime Dely: How Artificial Intelligence Will Revolutionize Transfusion Safety
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared on LinkedIn:
”From bag to patient: How artificial intelligence will revolutionize transfusion safety
Artificial intelligence won’t save lives on its own — not yet. But soon, it will learn to, quietly, behind the scenes of hospitals. And in the world of blood transfusion, its impact will be profound.
Every second, blood bags will continue to save lives.
But behind each transfusion will remain a complex equation: compatibility, urgency, availability, traceability… and the persistent risk of human error.
What if AI became our greatest ally in making all this safer?
In the coming years, AI will enter the transfusion chain:
- Predictive analysis of needs to prevent shortages
- Automated detection of anomalies in biological data
- Intelligent matching to minimize rare incompatibilities
Where technicians once relied solely on experience and intuition,
AI will step in — not to replace, but to reinforce human vigilance.
Soon, blood bank organizations and hospitals will deploy models capable of:
- Anticipating peaks in blood demand
- Predicting high-risk transfusions before they occur
But beyond technology, a deeper question will emerge — one of trust and ethics:
How will algorithms and human judgment coexist in a field where every drop counts?
So, what do you think — will AI become a cornerstone of transfusion safety, or remain just a supporting tool?”

Stay updated with Hemostasis Today.
-
Mar 16, 2026, 19:16Maha Othman: Delighted to See Our Article Receive The Eberhard F. Mammen Most Popular Article Award 2026
-
Mar 16, 2026, 19:03Limited Evidence for Anticoagulation Despite High VTE Risk in Sickle Cell Disease – RPTH
-
Mar 16, 2026, 18:59Bartosz Hudzik: Choosing The Right Anticoagulant for Acute Venous Thromboembolism
-
Mar 16, 2026, 18:54Michael Recht Appointed Chief Medical and Scientific Advisor to NBDF’s Pathway to Cures
-
Mar 16, 2026, 18:46David McIntosh: Moving Beyond Doubts and Ensuring the Safety of Plasma Donation
-
Mar 16, 2026, 18:42Ramy Abdelnaby: Exploring Advances in Antithrombotic Therapy for Noncardioembolic Ischemic Stroke
-
Mar 16, 2026, 18:27Christina (Tina) P: Help Advance Research and Support Patients with Antiphospholipid Syndrome
-
Mar 16, 2026, 18:20Ahmed Koriesh: Stroke Prevention in the New 2026 ACC/AHA Dyslipidemia Guideline
-
Mar 16, 2026, 18:13Nameer Ascandar: Outcomes After GI Bleeding in Patients with Rheumatoid Arthritis and AF on Long-Term Oral Anticoagulation